Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Hair Growth Composition Patented by Triple Hair Inc. - Happi
Patents

Hair Growth Composition Patented by Triple Hair Inc.

Canadian developer of treatments for alopecia develops composition with minoxidil, finasteride and latanoprost.

US Patent No. 11,696,883 B2 (Houfar Sekhavat); Triple Hair Inc., Montreal, has patented a  topical composition that is comprised of 2% to 5% minoxidil; finasteride in an amount greater than or equal to 0.01% and less than 0.225%; and 0.01% to 0.15% latanoprost. The composition is designed for topical application to a scalp.

In related news, Triple Hair Group Inc. in June received a “No Objection Letter” from Health Canada  allowing it to move forward with its Phase III clinical trials on its flagship prescription product, Therapy-07, in Canada. The trials will be aimed at measuring the effectiveness of Therapy-07 on hair regrowth to treat androgenic alopecia, according to the biotech company.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters